Triumph Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-30,761
Closed -$210K 292
2024
Q2
$210K Buy
+30,761
New +$210K 0.08% 222